Shiva Hadi Esfahani

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals”.

In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals

Pharmaceutical Research(2022)10.1007/s11095-022-03218-w

N/A

0DataRank · unranked

12 citations

Shiva Hadi Esfahani, Behnam Noorani, Dhaval Patel, Heidi Villalba, Yashwardhan Ghanwatkar +7 more

Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001339

N/A

0DataRank · unranked

7 citations

Srinidhi Jayaraman, Vardan T. Karamyan, Shiva Hadi Esfahani

Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators

Bioorganic & Medicinal Chemistry Letters(2022)10.1016/j.bmcl.2022.128669

N/A

0DataRank · unranked

7 citations

Shiva Hadi Esfahani, Saeideh Nozohouri, Shikha Kumari, Joanna Kocot, Yong Zhang +4 more

Challenges with the proposed ACE2 activation mechanism of diminazene aceturate

Clinical and Experimental Pharmacology and Physiology(2022)10.1111/1440-1681.13636

N/A

0DataRank · unranked

0 citations

Vardan T. Karamyan, Shiva Hadi Esfahani

Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals

Pharmaceutical Research(2023)10.1007/s11095-023-03619-5

N/A

0DataRank · unranked

6 citations

Sejal Sharma, Shirisha Jonnalagadda, Shikha Kumari, Aarfa Queen, Shiva Hadi Esfahani +7 more

High brain-blood barrier permeability highlights a new class of neurolysin activators as promising candidates for stroke treatment: a pilot pharmacokinetic study in mice

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.533120

N/A

0DataRank · unranked

0 citations

Sejal Sharma, Shiva Hadi Esfahani, Shirisha Jonnalagadda, Aarfa Queen, Saeideh Nozohouri +5 more

Structural basis of divergent substrate recognition and inhibition of human neurolysin

Scientific Reports(2024)10.1038/s41598-024-67639-w

N/A

0DataRank · unranked

2 citations

Sounak Bagchi, Jordis Bickel, Shiva Hadi Esfahani, Lulu Yin, Tiffany Cheng +3 more